Clinical Trials
9 trialsNCT06885424 2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
NCT04314401 2026-05-13
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
Active not recruiting
NCT04981119 2026-04-30
BASECAMP-1
A2 Biotherapeutics Inc.
Recruiting
NCT07327489 2026-01-08
ELEPHAS-05
Elephas
Recruiting
NCT07246759 2025-11-24
NEUTROFLOW
OncoHost Ltd.
Not yet recruiting
NCT04510129 2025-03-12
A Multicenter Cancer Biospecimen Collection Study
Cofactor Genomics, Inc.
Recruiting
NCT03232593 2022-08-24
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)
Hoffmann-La Roche
Completed
NCT05037825 2022-04-27
PARADIGM
VastBiome
Recruiting
NCT05230186 2022-02-09
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
TScan Therapeutics, Inc.
Unknown